Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 76 results found. Search for [ Central Drugs Standard Control Organisation ]

Results 1 to 21 of 76
PTI
June 2, 2020
The drug has been allowed for restricted emergency use for treatment of suspected or laboratory-confirmed cases of COVID-19 in adults and children hospitalised with severe symptoms, subject to several safeguards, the source said


PTI
May 30, 2020
Gilead Sciences Inc have entered into non-exclusive licensing agreements with pharma firms including three domestic majors Cipla, Jubilant Life Sciences and Hetero for manufacture and distribution of remdesivir


PTI
May 14, 2020
According to the guidance issued on Wednesday, the ICMR stated these tests can be done on blood/serum/plasma samples, the results of which are available within 30 minutes and the test comes positive after 7-10 days of infection


Joe C Mathew
April 28, 2020
While the legality of the issue will get sorted out in the coming days, one thing is certain that the scramble for a share in the thriving business of rapid diagnostic kit supplies for COVID-19 is leaving several grey areas for potential legal tussles


BusinessToday.In
New Delhi, April 24, 2020
To further India's self-reliance in testing, Mylab Solutions collaborates with Syngene International for Make in India raw materials, the company tweeted


PB Jayakumar
New Delhi, April 7, 2020
The vaccine is expected to provide long-lasting protection with a single dose administration with an anticipated safety profile similar to other licensed vaccines for active immunisation, said Indian Immunologicals Limited (IIL)


Joe C Mathew
New Delhi, April 2, 2020
Mylab is the first Indian company to get commercial approval for its testing kits named as Mylab PathoDetect COVID-19 Qualitative PCR kit; the testing kit is approved by Indian FDA/CDSCO and ICMR evaluation


Chitranjan Kumar
New Delhi, March 30, 2020
FMCG companies such as Nestle, HUL, ITC, P&G, Godrej Consumer, Dabur, Amul and others are set to gain ground amid sudden rise in demand due to anxiety buying and hoarding of daily essentials


Joe C Mathew
New Delhi, March 29, 2020
Test detects genetic signature of SARS-CoV-2 virus, also known as novel coronavirus or COVID-19, in swab samples that healthcare providers collect from back of patient's throat or nose


BusinessToday.In
New Delhi, March 24, 2020
Coronavirus India latest updates: Prime Minister Narendra Modi said on Tuesday that the nationwide lockdown will be in effect from midnight to save every Indian. The 21-day lockdown period is to prevent the further spread of COVID-19


Joe C Mathew
New Delhi, March 23, 2020
So far the Indian government has been sourcing millions of testing kits from Germany to facilitate testing to diagnose Coronavirus patients PAN-India


BusinessToday.In
New Delhi, March 5, 2020
Coronavirus live news update India: Both Egypt and South Africa reported their first cases of coronavirus infections, almost three month after the outbreak was first identified


PB Jayakumar
December 17, 2019
According to the report 'India: the emerging hub for biologics and biosimilars', the Indian pharmaceutical companies have launched 123 biosimilars and currently have 201 active biosimilars covering multiple indications in the development pipeline


Reuters
December 4, 2019
Trader groups have protested for years against e-pharmacies, saying they challenge their businesses and could allow medicines to be abused by being sold without proper verification


Joe C Mathew
November 28, 2019
Diagnostic imaging sector, largely dominated by big players, constitutes 36 per cent of the market, consumables and patient aids could be another 28 per cent, Invest India estimates


PTI
November 3, 2019



Joe C Mathew
New Delhi, October 25, 2019
Nano-formulations are not entirely new drugs but medicines that have better quality because of the technology-led delivery mechanisms that are used to make its administration in the body more effective


PTI
August 25, 2019



PTI
August 18, 2019



PB Jayakumar
New Delhi, July 19, 2019
Failed policies cause domestic manufactures to import medical devices, while the government wants India to list among top five medical devices manufacturing hubs in the world under the 'Make in India' initiative


PAGES 1 OF 4  1234